Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 256 - 270 of 308 items.
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Bedbugs: Don't bring them back from your vacation
AlertInformation update | 2019-03-05
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
Health Canada warns that products sold by A1 Herbal Ayurvedic Clinic Ltd. may pose serious health risks
AlertPublic advisory | 2019-01-28
Health Canada warns consumers that Pace, promoted as an alcohol substitute, is unauthorized and may pose serious health risks
AlertPublic advisory | 2018-12-21
One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error
AlertPublic advisory | 2018-12-21
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20